BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23474137)

  • 1. Giant cell myocarditis in a patient with a spondyloarthropathy after a drug hypersensitivity reaction.
    Mitoff PR; Mesana TG; Mielniczuk LM; Grenon J; Veinot JP; Cooper LT; Davies RA
    Can J Cardiol; 2013 Sep; 29(9):1138.e7-8. PubMed ID: 23474137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Giant cell myocarditis.
    Cooper LT; Berry GJ; Rizeq M; Schroeder JS
    J Heart Lung Transplant; 1995; 14(2):394-401. PubMed ID: 7779862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Giant cell myocarditis: first report of disease recurrence in the transplanted heart.
    Gries W; Farkas D; Winters GL; Costanzo-Nordin MR
    J Heart Lung Transplant; 1992; 11(2 Pt 1):370-4. PubMed ID: 1576144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphoma-like presentation in suspected rheumatoid arthritis due to sulphasalazine hypersensitivity syndrome.
    Shenoy P; Misra R; Jain M; Agarwal V
    N Z Med J; 2008 Jun; 121(1276):102-5. PubMed ID: 18574514
    [No Abstract]   [Full Text] [Related]  

  • 5. Photo-induced Stevens-Johnson syndrome due to sulfasalazine therapy.
    Borrás-Blasco J; Navarro-Ruiz A; Matarredona J; Devesa P; Montesinos-Ros A; González-Delgado M
    Ann Pharmacother; 2003 Sep; 37(9):1241-3. PubMed ID: 12921507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-B27 associated spondyloarthropathy, vasculitis, and amyloid enteropathy: response to infliximab.
    Stamp LK; O'Donnell JL
    J Rheumatol; 2005 Feb; 32(2):382-5. PubMed ID: 15693105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of serious heart failure by transplantation in giant cell myocarditis diagnosed by endomyocardial biopsy.
    Nieminen MS; Salminen US; Taskinen E; Heikkilä P; Partanen J
    J Heart Lung Transplant; 1994; 13(3):543-5. PubMed ID: 8061033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Giant-cell myocarditis without a symptom of heart failure seen in a patient with myasthenia gravis and concurrent Hashimoto's disease].
    Kanzato N; Nakasone I; Sunagawa O; Komine Y; Fukiyama K
    Rinsho Shinkeigaku; 2001 Nov; 41(11):813-7. PubMed ID: 12080616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Giant cell myocarditis in hypersensitivity reactions: is an early diagnose possible?
    Micozzi S; Pinto C; Seoane M; Carbone J; Tornero P
    Ann Allergy Asthma Immunol; 2015 Sep; 115(3):247-8. PubMed ID: 26165744
    [No Abstract]   [Full Text] [Related]  

  • 10. [A case of salazosulfapyridine induced hypersensitivity syndrome].
    Orita M; Katakura Y; Kobayashi M; Ishii T; Watanabe Y; Yotsuyanagi H; Suzuki M; Itoh F
    Nihon Shokakibyo Gakkai Zasshi; 2005 May; 102(5):600-4. PubMed ID: 15920959
    [No Abstract]   [Full Text] [Related]  

  • 11. [Severe drug hypersensitivity syndrome due to sulphasalazine in patient with rheumatoid arthritis].
    Gutierrez M; Filippucci E; Bugatti L; Bertolazzi C; Grassi W
    Reumatismo; 2009; 61(1):65-8. PubMed ID: 19370190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Seronegative spondylarthropathy: variable manifestations, common characteristics].
    van Rijthoven AW; Jacobs JW
    Ned Tijdschr Geneeskd; 2007 Jun; 151(25):1377-81. PubMed ID: 17668597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis and course of myocarditis: a survey in the medical clinics of Zurich University Hospital 1980 to 1998].
    Sauvant G; Bossart W; Kurrer MO; Follath F
    Schweiz Med Wochenschr; 2000 Sep; 130(36):1265-71. PubMed ID: 11028270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 3-week sulphasalazine syndrome strikes again.
    Lau G; Kwan C; Chong SM
    Forensic Sci Int; 2001 Nov; 122(2-3):79-84. PubMed ID: 11672959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ten-year experience with endomyocardial biopsy in myocarditis presenting with congestive heart failure: frequency, pathologic characteristics, treatment and follow-up.
    Arbustini E; Gavazzi A; Dal Bello B; Morbini P; Campana C; Diegoli M; Grasso M; Fasani R; Banchieri N; Porcu E; Pilotto A; Ponzetta M; Bellini O; Lucreziotti S; Viganò M
    G Ital Cardiol; 1997 Mar; 27(3):209-23. PubMed ID: 9199949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis, treatment, and outcome of giant-cell myocarditis in the era of combined immunosuppression.
    Kandolin R; Lehtonen J; Salmenkivi K; Räisänen-Sokolowski A; Lommi J; Kupari M
    Circ Heart Fail; 2013 Jan; 6(1):15-22. PubMed ID: 23149495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulfasalazine-induced hypersensitivity syndrome and hemophagocytic syndrome associated with reactivation of Epstein-Barr virus.
    Komatsuda A; Okamoto Y; Hatakeyama T; Wakui H; Sawada K
    Clin Rheumatol; 2008 Mar; 27(3):395-7. PubMed ID: 17952482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Life-threatening liver failure and severe dyscrasias in blood and lymph nodes caused by sulphasalazine].
    Kampmann P; Højlyng N; Pedersen M
    Ugeskr Laeger; 2006 Sep; 168(39):3331-3. PubMed ID: 17032600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long survival with giant cell myocarditis.
    Ren H; Poston RS; Hruban RH; Baumgartner WA; Baughman KL; Hutchins GM
    Mod Pathol; 1993 Jul; 6(4):402-7. PubMed ID: 8415583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible lenalidomide-induced Stevens-Johnson syndrome during treatment for multiple myeloma.
    Boruah PK; Bolesta S; Shetty SM
    Pharmacotherapy; 2011 Sep; 31(9):925. PubMed ID: 21923596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.